Source:http://linkedlifedata.com/resource/pubmed/id/20064536
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
7
|
| pubmed:dateCreated |
2010-4-5
|
| pubmed:abstractText |
Although stroke remains a leading cause of death and adult disability, numerous recent failures in clinical stroke trials have led to some pessimism in the field. Interestingly, NeuroAid (MLC601), a traditional medicine, particularly used in China, South East Asia and Middle East has been reported to have beneficial effects in patients, particularly in post-stroke complications. Here, we demonstrate in a rodent model of focal ischemia that NeuroAid II (MLC901) pre- and post-treatments up to 3 h after stroke improve survival, protect the brain from the ischemic injury and drastically decrease functional deficits. MLC601 and MLC901 also prevent neuronal death in an in vitro model of excitotoxicity using primary cultures of cortical neurons exposed to glutamate. In addition, MLC601/MLC901 treatments were shown to induce neurogenesis in rodent and human cells, promote cell proliferation as well as neurite outgrowth and stimulate the development of a dense axonal and dendritic network. MLC601 and MLC901 clearly represent a very interesting strategy for stroke treatment at different stages of the disease.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Jun
|
| pubmed:issn |
1873-7064
|
| pubmed:author | |
| pubmed:copyrightInfo |
(c) 2010 Elsevier Ltd. All rights reserved.
|
| pubmed:issnType |
Electronic
|
| pubmed:volume |
58
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
987-1001
|
| pubmed:meshHeading |
pubmed-meshheading:20064536-Animals,
pubmed-meshheading:20064536-Brain,
pubmed-meshheading:20064536-Brain Ischemia,
pubmed-meshheading:20064536-Cell Death,
pubmed-meshheading:20064536-Cell Line,
pubmed-meshheading:20064536-Cell Proliferation,
pubmed-meshheading:20064536-Cells, Cultured,
pubmed-meshheading:20064536-Disease Models, Animal,
pubmed-meshheading:20064536-Drugs, Chinese Herbal,
pubmed-meshheading:20064536-Glutamic Acid,
pubmed-meshheading:20064536-Humans,
pubmed-meshheading:20064536-Male,
pubmed-meshheading:20064536-Mice,
pubmed-meshheading:20064536-Mice, Inbred C57BL,
pubmed-meshheading:20064536-Neurogenesis,
pubmed-meshheading:20064536-Neurons,
pubmed-meshheading:20064536-Neuroprotective Agents,
pubmed-meshheading:20064536-Stroke,
pubmed-meshheading:20064536-Time Factors,
pubmed-meshheading:20064536-Treatment Outcome
|
| pubmed:year |
2010
|
| pubmed:articleTitle |
Neuroprotective and neuroproliferative activities of NeuroAid (MLC601, MLC901), a Chinese medicine, in vitro and in vivo.
|
| pubmed:affiliation |
Institut de Pharmacologie Moléculaire et Cellulaire, Centre National de la Recherche Scientifique (CNRS), Université de Nice Sophia Antipolis, 660 Route des Lucioles, 06560 Valbonne, France. heurteau@ipmc.cnrs.fr
|
| pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|